Crossmark

Glutamate dehydrogenase activity and non-ınvasive fibrosis ındices (APRI, AAR, FIB-4) compared to FibroScan in chronic hepatitis B and hepatocellular carcinoma

Crossref DOI link: https://doi.org/10.1007/s11845-026-04389-w

Published Online: 2026-04-17

Published Print: 2026-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Üremiş, Nuray https://orcid.org/0000-0002-3958-4352
Gişi, Kadir

Şakalar, Teoman

Tolun, Fatma İnanç
Funding

Funding for this research was provided by:

Kahramanmaras Sutcu Imam University
License Information

Text and Data Mining valid from 2026-04-17

Version of Record valid from 2026-04-17
More Information

Article History

Received: 6 January 2026

Accepted: 3 April 2026

First Online: 17 April 2026

Declarations

Ethical approval: The KSU Medical Research Ethics Committee approved this study with protocol number 2024/33–314.

Competing interests: The authors declare that they have no competing interests.

Data availability: The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Document is current

Any future updates will be listed below